Alkem Laboratories Limited (ALKEM.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 627.07B |
| Enterprise Value | 645.07B |
| P/E Ratio | 27.65 |
| PEG Ratio | -4.88 |
| Price/Sales Ratio | 3.95 |
| Price/Book Ratio | 4.15 |
| Enterprise/Revenue | 3.95 |
| Enterprise/EBITDA | 18.1 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.14 |
| Operating Margin | 0.17 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.16 |
Income Statement
| Revenue | 147.12B |
| Revenue/Share | 1,261.35 |
| Gross Profit | 96.2B |
| EBITDA | 34.14B |
| Net Income | 23.02B |
| Diluted EPS | 192.51 |
Balance Sheet
| Total Cash | 40.61B |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 1,200.09 |
Price History
| 52-Week Change | -9.95 |
| 52-Week High | 5,933.5 |
| 52-Week Low | 4,811 |
| Moving Average 50 Days | 5,260.18 |
| Moving Average 200 Days | 5,452.14 |
Statistics
| Average Volume | 139,805 |
| Shares Outstanding | 119.57M |
| % Held by Institutions | 0.02 |
Dividend And Splits
| Trailing Annual Dividend Rate | 53 |
| Trailing Annual Dividend Yield | 1.06 |
| Payout Ratio | 0.05 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
